Press Releases

Year

Mar 27, 2020

AnPac Bio Receives Accreditation for United States Laboratory from College of American Pathologists

SAN JOSE, Calif., March 27, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that its San Jose, CA lab

Mar 24, 2020

AnPac Bio Granted Important Novel Micro Medical Device Patent in the United States

SAN JOSE, Calif. , March 24, 2020 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the allowance by the

Feb 27, 2020

AnPac Bio Files Coronavirus Detection Patent and Initiates Related Research Project

SAN JOSE, Calif. , Feb. 27, 2020 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has filed a

Feb 06, 2020

AnPac Bio Gains Two New Insurance Customers

SAN JOSE, Calif. , Feb. 6, 2020 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio" or the "Company") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has gained two new

Jan 30, 2020

AnPac Bio Announces Pricing of Initial Public Offering

SAN JOSE, Calif. , Jan. 30, 2020 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio" or the "Company") (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has priced its initial

Press Releases

Press Releases

Quick Links

Contact Information